Literature DB >> 17374405

Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease.

Kristin K Anstrom1, Timothy Schallert, Martin T Woodlee, Avery Shattuck, David C S Roberts.   

Abstract

In rodent models of Parkinson's disease (PD), exercise or complex living environments introduced immediately before or during early stages of degeneration can provide beneficial effects on functional and/or neurochemical outcome. The goal of this study was to determine whether or not exposure to repetitive vibrissae-elicited forelimb placing, a dopamine-dependent sensorimotor movement, improves functional outcome in rats infused unilaterally with 6-OHDA. Prior to unilateral 6-OHDA infusions into the medial forebrain bundle, male Sprague-Dawley rats were randomly divided into groups exposed to one of five placing schedules: (1) two consecutive days pre-6-OHDA (PRE), (2) PRE+day 1 post-6-OHDA, (3) PRE+days 1, 2, 3 post-6-OHDA, (4) HANDLE, and (5) Sham infusion+handle. A session consisted of 180 total trials (90 left forelimb and 90 right forelimb trials) including 60 consecutive trials where vibrissae stimulation evoked ipsilateral forelimb movement and 30 consecutive trials where the ipsilateral forelimb was restrained so that vibrissae evoked contralateral forelimb movement (cross-midline placing). All groups were exposed to forelimb placing sessions on post-infusion days 7 and 14. The ability of vibrissae stimulation to elicit an ipsilateral response of the 6-OHDA affected forelimb was assessed on all days. Animals were sacrificed on post-lesion day 15 and substantia nigra tyrosine hydroxylase immunoreactivity (TH-ir) quantified. Repetitive forelimb placing had a significant effect on behavioral performance for all groups compared to the HANDLE group, but only the PRE+123 group was not significantly different from SHAM controls. Only the PRE+123 group showed significant sparing of TH-ir compared to the HANDLE group. These data suggest that extensive repetitive exposure to a sensorimotor task may provide therapeutic effects in an animal model of PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374405     DOI: 10.1016/j.bbr.2007.01.028

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  20 in total

1.  Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse.

Authors:  Qing-Hui Zhou; Eric Ka-Wai Hui; Jeff Zhiqiang Lu; Ruben J Boado; William M Pardridge
Journal:  Brain Res       Date:  2011-01-26       Impact factor: 3.252

2.  A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease.

Authors:  Michelle R Ciucci; Lisa Vinney; Emerald J Wahoske; Nadine P Connor
Journal:  J Commun Disord       Date:  2010-04-08       Impact factor: 2.288

Review 3.  Targeted exercise therapy for voice and swallow in persons with Parkinson's disease.

Authors:  John A Russell; Michelle R Ciucci; Nadine P Connor; Timothy Schallert
Journal:  Brain Res       Date:  2010-03-15       Impact factor: 3.252

4.  Exercise protects against MPTP-induced neurotoxicity in mice.

Authors:  Kimberly M Gerecke; Yun Jiao; Amar Pani; Vishwajeeth Pagala; Richard J Smeyne
Journal:  Brain Res       Date:  2010-01-29       Impact factor: 3.252

Review 5.  Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.

Authors:  Michelle R Ciucci; Sean T Ma; Jacqueline R Kane; Allison M Ahrens; Timothy Schallert
Journal:  Parkinsonism Relat Disord       Date:  2008-06-27       Impact factor: 4.891

6.  Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease.

Authors:  Jacqueline R Kane; Michelle R Ciucci; Amber N Jacobs; Nathan Tews; John A Russell; Allison M Ahrens; Sean T Ma; Joshua M Britt; Lawrence K Cormack; Timothy Schallert
Journal:  J Commun Disord       Date:  2011-04-30       Impact factor: 2.288

7.  Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier.

Authors:  Ailing Fu; Qing-Hui Zhou; Eric Ka-Wai Hui; Jeff Zhiqiang Lu; Ruben J Boado; William M Pardridge
Journal:  Brain Res       Date:  2010-06-30       Impact factor: 3.252

8.  Enhanced lateral inhibition in the barrel cortex by deletion of phospholipase C-related catalytically inactive protein-1/2 in mice.

Authors:  Hiroki Toyoda; Mitsuru Saito; Hajime Sato; Tsutomu Kawano; Shinpei Kawakami; Hirofumi Yatani; Takashi Kanematsu; Masato Hirata; Youngnam Kang
Journal:  Pflugers Arch       Date:  2014-08-28       Impact factor: 3.657

Review 9.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

10.  Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy.

Authors:  Yun Zhang; William M Pardridge
Journal:  Pharm Res       Date:  2008-12-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.